BHCM
OFIX icon

Brevan Howard Capital Management’s Orthofix Medical OFIX Stock Holding History

Brevan Howard Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,565
Closed -$328K – 2440
2026
Q1 		$328K Buy
28,565
+1,130
+4% +$14.9K ﹤0.01% 1564
2025
Q4 		$416K Buy
+27,435
New +$419K ﹤0.01% 1199

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Brevan Howard Capital Management's OFIX Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Orthofix Medical (OFIX) in Q2 2026, closing a stake of 28,565 shares — an estimated $328K sold.

Brevan Howard Capital Management first reported a position in OFIX in Q4 2025 and held it in 2 quarters. The position peaked at $416K in Q4 2025. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Orthofix Medical position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 28,565 Orthofix Medical shares in Q2 2026, an estimated $328K.
  • Brevan Howard Capital Management first reported a position in Orthofix Medical in Q4 2025 and held it in 2 quarters.
  • Brevan Howard Capital Management's Orthofix Medical position peaked at $416K in Q4 2025.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.